ES2073246T3 - Derivados de pirazina. - Google Patents
Derivados de pirazina.Info
- Publication number
- ES2073246T3 ES2073246T3 ES92303970T ES92303970T ES2073246T3 ES 2073246 T3 ES2073246 T3 ES 2073246T3 ES 92303970 T ES92303970 T ES 92303970T ES 92303970 T ES92303970 T ES 92303970T ES 2073246 T3 ES2073246 T3 ES 2073246T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- derivatives
- piracina
- rental
- rent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 1
- -1 PHENYL RING Chemical group 0.000 abstract 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract 1
- 150000004703 alkoxides Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10004991 | 1991-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2073246T3 true ES2073246T3 (es) | 1995-08-01 |
Family
ID=14263648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92303970T Expired - Lifetime ES2073246T3 (es) | 1991-05-01 | 1992-05-01 | Derivados de pirazina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5459142A (https=) |
| EP (1) | EP0511879B1 (https=) |
| JP (1) | JP2599665B2 (https=) |
| KR (1) | KR0183043B1 (https=) |
| CN (1) | CN1038586C (https=) |
| CA (1) | CA2067663A1 (https=) |
| DE (1) | DE69201748T2 (https=) |
| DK (1) | DK0511879T3 (https=) |
| ES (1) | ES2073246T3 (https=) |
| MX (1) | MX9202022A (https=) |
| TW (1) | TW197429B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5872138A (en) * | 1996-09-13 | 1999-02-16 | Merck & Co., Inc. | Thrombin inhibitors |
| US5869487A (en) * | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
| US5866573A (en) * | 1997-04-21 | 1999-02-02 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6087373A (en) * | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
| US6133297A (en) * | 1997-09-30 | 2000-10-17 | Merck & Co., Inc. | Thrombin inhibitors |
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| PL200955B1 (pl) | 1998-08-20 | 2009-02-27 | Toyama Chemical Co Ltd | Przeciwwirusowa kompozycja farmaceutyczna i jej zastosowanie oraz zawierająca azot heterocykliczna pochodna karboksamidu |
| EP1117660A4 (en) * | 1998-09-28 | 2002-01-09 | Merck & Co Inc | Thrombin Inhibitors |
| WO2000026211A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| EP1124823A1 (en) | 1998-10-30 | 2001-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
| US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
| UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| CA2374654A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Thrombin inhibitors |
| WO2001038323A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| CA2403558A1 (en) | 2000-03-23 | 2001-09-27 | Merck & Co., Inc. | Thrombin inhibitors |
| AU2001281817B2 (en) * | 2000-06-21 | 2005-11-24 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives |
| WO2004035571A1 (en) * | 2002-10-15 | 2004-04-29 | Rigel Pharmaceuticals, Inc. | Substituted indoles and their use as hcv inhibitors |
| BRPI0708337A2 (pt) | 2006-02-28 | 2011-05-24 | Helicon Therapeutics Inc | pipirazinas terapêutica como inibidores pde4 |
| US8927546B2 (en) | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| US20100258224A1 (en) * | 2007-10-19 | 2010-10-14 | Francesco Mangano | Camera cover |
| AU2020352311B2 (en) * | 2019-09-24 | 2023-11-09 | Wuhan Createrna Science And Technology Co., Ltd. | IRAK inhibitor and preparation method therefor and use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3259622A (en) * | 1962-09-07 | 1966-07-05 | Merck & Co Inc | 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids |
| US4041032A (en) * | 1974-01-16 | 1977-08-09 | Yamanouchi Pharmaceutical Co., Ltd. | Pyrazine derivatives |
| SU959895A1 (ru) * | 1981-01-06 | 1982-09-23 | Челябинский конструкторско-технологический институт автоматизации и механизации в автомобилестроении | Устройство дл регенерации формовочных и стержневых смесей |
| JPS6054931B2 (ja) * | 1981-11-24 | 1985-12-03 | 旭硝子株式会社 | １，１，１，３，３，３‐ヘキサフルオロ‐２‐プロパノールの製法 |
| DE3421452C2 (de) * | 1984-06-08 | 1986-05-22 | Kuka Schweissanlagen + Roboter Gmbh, 8900 Augsburg | Vorrichtung zum automatischen Erfassen bzw. Lösen eines Werkzeugträgers bei einem Manipulator |
| GB8427735D0 (en) * | 1984-11-02 | 1984-12-12 | Fujisawa Pharmaceutical Co | Piperazine compound |
| US4894453A (en) * | 1986-06-30 | 1990-01-16 | Toyo Jozo Kabushiki Kaisha | 2-substituted alkoxy-3-substituted-pyrazines |
| ES2054748T3 (es) * | 1987-08-11 | 1994-08-16 | Otsuka Pharma Co Ltd | Un procedimiento para proporcionar un compuesto de pirazinoxido. |
| US5175144A (en) * | 1988-11-29 | 1992-12-29 | The Johns Hopkins University | Method of retarding the progression of chronic renal failure |
| US5238938A (en) * | 1989-02-10 | 1993-08-24 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives |
-
1992
- 1992-04-30 TW TW081103399A patent/TW197429B/zh active
- 1992-04-30 CN CN92103130A patent/CN1038586C/zh not_active Expired - Fee Related
- 1992-04-30 CA CA002067663A patent/CA2067663A1/en not_active Abandoned
- 1992-04-30 MX MX9202022A patent/MX9202022A/es unknown
- 1992-04-30 JP JP4110548A patent/JP2599665B2/ja not_active Expired - Lifetime
- 1992-05-01 DE DE69201748T patent/DE69201748T2/de not_active Expired - Fee Related
- 1992-05-01 DK DK92303970.5T patent/DK0511879T3/da active
- 1992-05-01 ES ES92303970T patent/ES2073246T3/es not_active Expired - Lifetime
- 1992-05-01 EP EP92303970A patent/EP0511879B1/en not_active Expired - Lifetime
- 1992-05-01 KR KR1019920007486A patent/KR0183043B1/ko not_active Expired - Fee Related
-
1993
- 1993-08-23 US US08/110,797 patent/US5459142A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0511879B1 (en) | 1995-03-22 |
| DK0511879T3 (da) | 1995-06-06 |
| AU652824B2 (en) | 1994-09-08 |
| US5459142A (en) | 1995-10-17 |
| JP2599665B2 (ja) | 1997-04-09 |
| CN1067053A (zh) | 1992-12-16 |
| KR920021518A (ko) | 1992-12-18 |
| TW197429B (https=) | 1993-01-01 |
| CN1038586C (zh) | 1998-06-03 |
| DE69201748T2 (de) | 1995-07-20 |
| MX9202022A (es) | 1992-11-01 |
| KR0183043B1 (ko) | 1999-05-01 |
| EP0511879A1 (en) | 1992-11-04 |
| DE69201748D1 (de) | 1995-04-27 |
| JPH05170747A (ja) | 1993-07-09 |
| AU1590892A (en) | 1992-11-05 |
| CA2067663A1 (en) | 1992-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2073246T3 (es) | Derivados de pirazina. | |
| ES2150918T3 (es) | 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas. | |
| IT1255192B (it) | Benzofuran-2-oni tiometilati | |
| ES2173683T3 (es) | Inhibidor del radical superoxido. | |
| PE23196A1 (es) | Compuesto util para tratar infecciones por retrovirus | |
| AR015103A1 (es) | Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones que los contienen e intermediarios | |
| YU491A (sh) | 3-aminopiperidinski derivati | |
| AR012489A1 (es) | Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y | |
| ES2113081T3 (es) | 1,4-benzotiazepinas utiles como agentes neurologicos. | |
| SE9600164D0 (sv) | Stabilisatorkombination | |
| DE3462504D1 (de) | Indole-3-carboxamide derivatives | |
| ES2108250T3 (es) | Composiciones fungicidas. | |
| ES2085940T3 (es) | 4-amino-3-piridinoles sustituidos, un procedimiento para su preparacion y su uso como medicamentos. | |
| SE8505887D0 (sv) | Indoler | |
| BR9901088A (pt) | Diresorcinil-alcóxi-e-arilóxi-s-triazinas. | |
| AR011886A1 (es) | Compuestos atropisomeros de 3-heteroaril-4-(3h)-quinazolinonas y composiciones farmaceuticas que los contienen | |
| DK118083A (da) | Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
| ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| ES2063815T3 (es) | 2-alquil-3-benzoilbenzofuranos y composiciones farmaceuticas que los contienen. | |
| AR021114A1 (es) | Procedimiento de fotoestabilizacion de filtros solares derivados de 1,3,5-triazina | |
| ES2075976T3 (es) | Derivados de aminoacido y su empleo como agentes antiviricos. | |
| CO5210898A1 (es) | Combinaciones sienrgicas de fungicida del tipo valinamida y fenamidona | |
| NZ218453A (en) | Pharmaceutical compositions containing a synergistic mixture of a dihydropyridine derivative and pyridazodiazepine derivative | |
| PE296A1 (es) | Derivados de 2-imidazolina-5-onas fungicidas | |
| AR246972A1 (es) | Un procedimiento para producir compuestos de benzodiazepina, y compuestos intermediarios utiles en dicho procedimiento. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 511879 Country of ref document: ES |